Kawashima procedure: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tag: Reverted
No edit summary
Tag: Manual revert
 
Line 30: Line 30:
{{stub}}
{{stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 17:28, 18 March 2025

Kawashima procedure is a surgical procedure used in the treatment of certain congenital heart defects, particularly those involving single-ventricle physiology. Named after the Japanese surgeon who first described it, Dr. Kawashima, this procedure is often used as a palliative treatment for patients with complex heart defects who are not candidates for a more definitive repair.

Indications[edit]

The Kawashima procedure is typically indicated for patients with single-ventricle physiology who also have anomalous pulmonary venous connection to the superior vena cava (SVC) or the right atrium. This includes conditions such as heterotaxy syndrome, asplenia syndrome, and polysplenia syndrome.

Procedure[edit]

The Kawashima procedure involves the redirection of blood flow from the SVC to the pulmonary arteries, bypassing the heart. This is achieved by disconnecting the SVC from the heart and connecting it to the pulmonary arteries. The goal of the procedure is to improve oxygenation of the blood by allowing deoxygenated blood from the upper body to flow directly to the lungs, bypassing the single functioning ventricle.

Outcomes[edit]

While the Kawashima procedure is a palliative treatment and not a cure, it can significantly improve the quality of life for patients with complex heart defects. It can help to alleviate symptoms such as cyanosis (bluish discoloration of the skin due to low oxygen levels), fatigue, and shortness of breath. However, long-term outcomes can vary widely depending on the specific heart defect and the overall health of the patient.

See also[edit]

References[edit]

<references />

Error creating thumbnail:
This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia